Evaluation of spontaneous adverse event reports for congenital and neonatal birth problems attributed to ondansetron within the FDA adverse events reporting system (FAERS)

Mohamed A Mekkawy; Ola F Khedr; Hala Shokr; Yasmin H Elsobky

Evaluation of spontaneous adverse event reports for congenital and neonatal birth problems attributed to ondansetron within the FDA adverse events reporting system (FAERS)

Mohamed A Mekkawy, Ola F Khedr, Hala Shokr, Yasmin H Elsobky

Pharmacy

Research output: Chapter in Book/Conference proceeding › Conference contribution › peer-review

Original language	English
Title of host publication	Pharmacoepidemiology and drug safety
Pages	230-230
Number of pages	1
Volume	27
Publication status	Published - 2018

Cite this

@inproceedings{00b7a88643194ac29967a3b26b0bde67,

title = "Evaluation of spontaneous adverse event reports for congenital and neonatal birth problems attributed to ondansetron within the FDA adverse events reporting system (FAERS)",

author = "Mekkawy, {Mohamed A} and Khedr, {Ola F} and Hala Shokr and Elsobky, {Yasmin H}",

year = "2018",

language = "English",

volume = "27",

pages = "230--230",

booktitle = "Pharmacoepidemiology and drug safety",

}

Evaluation of spontaneous adverse event reports for congenital and neonatal birth problems attributed to ondansetron within the FDA adverse events reporting system (FAERS). / Mekkawy, Mohamed A; Khedr, Ola F; Shokr, Hala et al.
Pharmacoepidemiology and drug safety. Vol. 27 2018. p. 230-230.

Research output: Chapter in Book/Conference proceeding › Conference contribution › peer-review

TY - GEN

T1 - Evaluation of spontaneous adverse event reports for congenital and neonatal birth problems attributed to ondansetron within the FDA adverse events reporting system (FAERS)

AU - Mekkawy, Mohamed A

AU - Khedr, Ola F

AU - Shokr, Hala

AU - Elsobky, Yasmin H

PY - 2018

Y1 - 2018

M3 - Conference contribution

VL - 27

SP - 230

EP - 230

BT - Pharmacoepidemiology and drug safety

ER -